The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Positron Emission Tomographic Analysis of Central D1 and D2 Dopamine Receptor Occupancy in Patients Treated With Classical Neuroleptics and Clozapine: Relation to Extrapyramidal Side Effects
Abstract
Positron emission tomography and selective radioligands were used to determine D1 and D2 dopamine receptor occupancy induced by neuroleptics in the basal ganglia of drug-treated schizophrenic patients. In 22 patients treated with conventional dosages of classical neuroleptics, the D2 occupancy was 70% to 89%. Patients with acute extrapyramidal syndromes had a higher D2 occupancy than those without side effects. This finding indicates that neuroleptic-induced extrapyramidal syndromes are related to the degree of central D2 occupancy induced in the basal ganglia. In five patients treated with clozapine, the prototype atypical antipsychotic drug, a lower D2 occupancy of 38% to 63% was found. This finding demonstrates that clozapine is also "atypical" with respect to the central D2 occupancy in patients. During treatment with clozapine, there is a low frequency of extrapyramidal syndromes, which accordingly may reflect the comparatively low D2 occupancy induced by clinical doses of clozapine. Classical neuroleptics, like haloperidol or sulpiride, did not cause any evident D1 occupancy, but the thioxanthene flupentixol induced a 36% to 44% occupancy. In four patients treated with clozapine, the D1 occupancy was 38% to 52%. The D1 occupancy induced by clozapine and flupentixol may contribute to the antipsychotic effect of these drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An analysis of variance test for normality (complete samples)
SHAPIRO, S. S., & WILK, M. B. (1965) · Biometrika · doi:10.1093/biomet/52.3-4.591 · Cited by 23,480
Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS
SIMPSON, G. M., B., M., B., G., ANGUS, J. W. S., P., F. R. C., & M., D. P. (1970) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1970.tb02066.x · Cited by 3,264
Sokoloff, P., Giros, B., Martres, M.-P., Bouthenet, M.-L., & Schwartz, J.-C. (1990) · Nature · doi:10.1038/347146a0 · Cited by 2,609
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220
A Rating Scale for Drug-Induced Akathisia
Barnes, T. R. E. (1989) · British Journal of Psychiatry · doi:10.1192/bjp.154.5.672 · Cited by 2,170
Carlsson, A., & Lindqvist, M. (1963) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1963.tb01730.x · Cited by 2,148
Van Tol, H. H. M., Bunzow, J. R., Guan, H.-C., Sunahara, R. K., Seeman, P., Niznik, H. B., & Civelli, O. (1991) · Nature · doi:10.1038/350610a0 · Cited by 2,014
Antipsychotic drug doses and neuroleptic/dopamine receptors
SEEMAN, P., LEE, T., CHAU-WONG, M., & WONG, K. (1976) · Nature · doi:10.1038/261717a0 · Cited by 1,622
Receptor activity and turnover of dopamine and noradrenaline after neuroleptics
Andén, N.-E., Butcher, S. G., Corrodi, H., Fuxe, K., & Ungerstedt, U. (1970) · European Journal of Pharmacology · doi:10.1016/0014-2999(70)90006-3 · Cited by 1,026
Antischizophrenic Drugs: Chronic Treatment Elevates Dopamine Receptor Binding in Brain
Burt, D. R., Creese, I., & Snyder, S. H. (1977) · Science · doi:10.1126/science.847477 · Cited by 1,024
Kebabian, J. W., Petzold, G. L., & Greengard, P. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.8.2145 · Cited by 1,022
Quantitative Analysis of D2 Dopamine Receptor Binding in the Living Human Brain by PET
Farde, L., Hall, H., Ehrin, E., & Sedvall, G. (1986) · Science · doi:10.1126/science.2867601 · Cited by 831
Self-citationWong, D. F., Wagner, H. N., Dannals, R. F., Links, J. M., Frost, J. J., Ravert, H. T., Wilson, A. A., Rosenbaum, A. E., Gjedde, A., Douglass, K. H., et al. (1984) · Science · doi:10.1126/science.6334363 · Cited by 697
Central D2-Dopamine Receptor Occupancy in Schizophrenic Patients Treated With Antipsychotic Drugs
Farde, L. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800250087012 · Cited by 692
Self-citation(1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.12.1518 · Cited by 541
Farde, L. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810150013003 · Cited by 530
Self-citationThe significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs.
van Rossum, J. M. (1966) · PubMed · Cited by 510
Kuczenski, R., & Segal, D. (1989) · The Journal of Neuroscience · doi:10.1523/jneurosci.09-06-02051.1989 · Cited by 398
Increased Brain Dopamine and Dopamine Receptors in Schizophrenia
Mackay, A. V. P. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290090001001 · Cited by 397
D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics
Farde, L., Wiesel, F. A., Nordstr�m, A. L., & Sedvall, G. (1989) · Psychopharmacology · doi:10.1007/bf00442555 · Cited by 325
Self-citationDose equivalence of the anti-psychotic drugs
Davis, J. M. (1974) · Journal of Psychiatric Research · doi:10.1016/0022-3956(74)90071-5 · Cited by 324
Farde, L., Ehrin, E., Eriksson, L., Greitz, T., Hall, H., Hedström, C. G., Litton, J. E., & Sedvall, G. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.11.3863 · Cited by 300
Self-citationThe Effect of Neuroleptics on Serum Prolactin in Schizophrenic Patients
Meltzer, H. Y. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770030003001 · Cited by 294
Effect of clozapine on the turnover of dopamine in the corpus striatum and in the limbic system
Andén, N.-E., & Stock, G. (1973) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1973.tb10025.x · Cited by 291
PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride
Farde, L., Halldin, C., Stone-Elander, S., & Sedvall, G. (1987) · Psychopharmacology · doi:10.1007/bf00210831 · Cited by 283
Self-citationQuantification of Neuroreceptors in the Living Human Brain. I. Irreversible Binding of Ligands
Wong, D. F., Gjedde, A., & Wagner, H. N. (1986) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1986.27 · Cited by 277
Clozapine: neuroleptic-induced EPS and tardive dyskinesia
Casey, D. E. (1989) · Psychopharmacology · doi:10.1007/bf00442559 · Cited by 251
Zetterström, T., Sharp, T., & Ungerstedt, U. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90674-5 · Cited by 246
Waddington, J. L., & O'Boyle, K. M. (1989) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(89)90046-6 · Cited by 203
Kornhuber, J., Riederer, P., Reynolds, G. P., Beckmann, H., Jellinger, K., & Gabriel, E. (1989) · Journal of Neural Transmission · doi:10.1007/bf01250639 · Cited by 189
Halldin, C., Stone-Elander, S., Farde, L., Ehrin, E., Fasth, K.-J., Långström, B., & Sedvall, G. (1986) · International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes · doi:10.1016/0883-2889(86)90044-4 · Cited by 174
Self-citationEffect of clozapine on human serum prolactin levels
(1979) · American Journal of Psychiatry · doi:10.1176/ajp.136.12.1550 · Cited by 171
Human dopamine receptor subtypes?in vitro binding analysis using3H-SCH 23390 and3H-raclopride
Hall, H., Farde, L., & Sedvall, G. (1988) · Journal of Neural Transmission · doi:10.1007/bf01244618 · Cited by 149
Self-citationSmith, M., Wolf, A. P., Brodie, J. D., Arnett, C. D., Barouche, F., Shiue, C., Fowler, J. S., Russell, J. A. G., MacGregor, R. R., Wolkin, A., et al. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90048-0 · Cited by 141
Changes in rat striatal dopamine turnover and receptor activity during one years neuroleptic
Clow, A., Theodorou, A. E., Jenner, P. G., & MARSDEN, C. D. (1980) · European Journal of Pharmacology · doi:10.1016/0014-2999(80)90437-9 · Cited by 134
Performance Study of the PC-384 Positron Camera System for Emission Tomography of the Brain
Litton, J.-E., Bergström, M., Eriksson, L. I., Böhm, C., Blomqvist, G., & Kesselberg, M. (1984) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-198402000-00016 · Cited by 132
Lewander, T., Westerbergh, S. ‐., & Morrison, D. P. (1990) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1990.tb05297.x · Cited by 132
Baron, J., Martinot, J. L., Cambon, H., Boulenger, J.-P., Poirier, M. F., Caillard, V., Blin, J., Huret, J. D., Loc’h, C., & Maziere, B. (1989) · Psychopharmacology · doi:10.1007/bf00589893 · Cited by 127
Baron, J., Maziere, B., Loc’h, C., Cambon, H., Sgouropoulos, P., Bonnet, A. M., & Agid, Y. (1986) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1986.26 · Cited by 110
Cortés, R., Camps, M., Gueye, B., Probst, A., & Palacios, J. M. (1989) · Brain Research · doi:10.1016/0006-8993(89)90031-0 · Cited by 109
Andersen, P. H. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90492-x · Cited by 108
Owen, F., Cross, A. J., Waddington, J. L., Poulter, M., Gamble, S. J., & Crow, T. J. (1980) · Life Sciences · doi:10.1016/0024-3205(79)90188-7 · Cited by 91
Clozapine: Plasma levels and prolactin response
Kane, J. M., Cooper, T. B., Sachar, E. J., Halpern, F. S., & Bailine, S. H. (1981) · Psychopharmacology · doi:10.1007/bf00429215 · Cited by 81
Elevation of Dopamine D2 Receptors in Schizophrenia is Underestimated by Radioactive Raclopride
Seeman, P. M., Niznik, H. B., & Guan, H. C. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810240090014 · Cited by 68
Halldin, C., Farde, L., Högberg, T., Hall, H., Ström, P., Ohlberger, A., & Solin, O. H. (1991) · International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology · doi:10.1016/0883-2897(91)90096-4 · Cited by 62
Self-citationZhang, W., Tilson, H. A., Stachowiak, M. K., & Hong, J. (1989) · Brain Research · doi:10.1016/0006-8993(89)90387-9 · Cited by 56
Cited by
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
Hiemke, C., Bergemann, N., Clement, H., Conca, A., Deckert, J., Domschke, K., Eckermann, G., Egberts, K., Gerlach, M., Greiner, C., et al. (2018) · Pharmacopsychiatry · doi:10.1055/s-0043-116492 · Cited by 1,446
Laruelle, M., Abi-Dargham, A., van Dyck, C. H., Gil, R., D'Souza, C. D., Erdos, J., McCance, E., Rosenblatt, W., Fingado, C., Zoghbi, S. S., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9235 · Cited by 1,291
Evidence for striatal dopamine release during a video game
Koepp, M. J., Gunn, R. N., Lawrence, A. D., Cunningham, V. J., Dagher, A., Jones, T., Brooks, D. J., Bench, C. J., & Grasby, P. M. (1998) · Nature · doi:10.1038/30498 · Cited by 1,279
Molecular imaging in drug development
Willmann, J. K., van Bruggen, N., Dinkelborg, L. M., & Gambhir, S. S. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2290 · Cited by 1,171
Kapur, S., & Seeman, P. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.360 · Cited by 1,140
Metadata
- Authors
- Farde, L.
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 1992-07-01
- Volume
- 49
- Issue
- 7
- Pages
- 538
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2072069319
- Cited by
- 1,419
- References
- 47
- FWCI
- 47.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.